ARCHIVES

PDQ Used Mainly For Information To Public, Not Much By Non-Oncologists, Evaluation Finds

This article is from The Cancer Letter archive.

Vol. 15 No. 33 | August 18, 1989

Download PDF Visit The Full Archive

Related Articles

Drug Approvals; Zykadia Granted Accelerated Approval For ALK+ NSCLC; ADXS-HPV Grated Orphan Drug Designation

May 9, 2014

NCI’s Drug Screen Tests 400 Agents A Week; Recompetition Of Contracts Approved

February 26, 1993

Breast Cancer Survivors Who Take Aspirin Have 50% Reduced Risk Of Metastasis

February 26, 2010

NCI-Approved Clinical Trials

December 30, 2005

In Brief: Senate Subcommittee Recommends $1 .52 Billion

September 25, 1987

NIH Funding Opportunities Listed

March 13, 2009